Delivery Order SPE2DB24D2205-SPE2DB25FECVA
- Not listed
- The Defense Logistics Agency Medical Supply Chain awarded a delivery order to AmerisourceBergen Drug Corp on July 16, 2025, for the supply of Sodium Bicarbonate 8.4% in 50ml vials with a ceiling value of $1,087.93. This is a firm fixed price, competitively awarded delivery order with no set-aside designation, representing a child contract under AmerisourceBergen's broader pharmaceutical supply agreement. The place of performance is Conshohocken, Pennsylvania, with an ultimate completion date...
- The Defense Logistics Agency (DLA) awarded a delivery order valued at $1,609.02 to AmerisourceBergen Drug Corp on April 21, 2025, for the supply of Sodium Bicarbonate 8.4% in 50 milliliter vials. This is a firm fixed-price, non-set-aside contract with an ultimate completion date of April 22, 2025, and performance at AmerisourceBergen's Conshohocken, Pennsylvania facility. The delivery order is issued under the company's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical...
- AmerisourceBergen Drug Corp was awarded a competitive delivery order valued at $1,610.85 on June 18, 2025, by the Defense Logistics Agency's Medical Supply Chain to supply Sodium Bicarbonate 8.4% in 50ml vials. The contract is firm fixed price with no set-aside designation and carries an ultimate completion date of June 20, 2025. Performance will be executed from the awardee's corporate office location in Conshohocken, Pennsylvania. This delivery order represents a child award under...
- The Defense Logistics Agency awarded a delivery order valued at $1,251.42 to AmerisourceBergen Drug Corp for Sodium Bicarbonate 4.2% vials (5ml) on September 4, 2025, with an ultimate completion date of September 5, 2025. This firm fixed-price delivery order was competitively awarded without set-aside designation and will be performed at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. The award represents a child contract under AmerisourceBergen's larger Indefinite...
- The Defense Logistics Agency (DLA) awarded a delivery order to AmerisourceBergen Drug Corp on August 4, 2025, for the supply of Sodium Bicarbonate 4.2% Vial 5mL, with a contract ceiling value of $4,731.23. This is a firm fixed price delivery order with an ultimate completion date of August 5, 2025. The contract was not set aside for small businesses or other designated categories and was competitively awarded through open competition. AmerisourceBergen Drug Corp, headquartered in Conshohocken,...
- The U.S. Defense Logistics Agency Medical Supply Chain awarded a delivery order to AmerisourceBergen Drug Corp on June 2, 2025, for the supply of Sodium Bicarbonate 4.2% in 5mL vials. The competitively awarded, firm fixed-price contract has a ceiling value of $3,125.25 with an ultimate completion date of June 3, 2025. This delivery order represents a child contract executed under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, designated as SPE2DX,...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on August 27, 2025, for the supply of Sodium Bicarbonate 8.4% Vial 50ML pharmaceutical product with a ceiling value of $8,130.14. This non-competitive, firm fixed-price delivery order represents a child contract under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, designated SPE2DX and valued at $999,999,999.00 through December 2026. The product will be performed at...
- The U.S. Defense Logistics Agency's Medical Supply Chain awarded a delivery order to AmerisourceBergen Drug Corp on June 27, 2025, for the supply of Sodium Bicarbonate 8.4% syringes in 50mL quantities. The contract is valued at $1,069.10 with a firm fixed price structure and carries no set-aside designation, indicating it was competitively awarded. The award represents a child delivery order under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical...
- The Defense Logistics Agency awarded a $5,329.17 firm fixed price delivery order to Amerisourcebergen Drug Corporation for sodium bicarbonate 8.4% vials. As the prime contractor, Amerisourcebergen will deliver 50 milliliter vials of the pharmaceutical product to its facility in Conshohocken, Pennsylvania by August 4, 2023 to fulfill requirements under the Agency's pharmaceutical supply chain support program. No subcontractors or set aside designations were identified. The order was placed...
- The U.S. Defense Logistics Agency (DLA) awarded a firm fixed price delivery order contract to Amerisourcebergen Drug Corp, a subsidiary of Amerisourcebergen Corporation, to provide 50 mL vials of 8.4% sodium bicarbonate. The $1,338.78 contract has a completion date of February 1, 2024. Amerisourcebergen Drug Corp, a for-profit organization, is the prime contractor and has previously received numerous DLA contracts to supply pharmaceuticals, medical supplies, and distribution services to...
- SPE2DB24D2205Indefinite Delivery Contract
- SPE2DB24D2205-SPE2DB25FECVADelivery Order
The Defense Logistics Agency awarded a $1,398.02 delivery order to AmerisourceBergen Drug Corp on May 27, 2025, for the supply of Sodium Bicarbonate 8.4% in 10mL vials. This is a firm fixed-price, non-set-aside contract with an ultimate completion date of May 28, 2025, and will be performed at AmerisourceBergen's facility in Conshohocken, Pennsylvania. The delivery order represents a child contract under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, designated SPE2DX, which carries a $999.999 billion ceiling value through December 2026 and serves as the company's primary vehicle for supplying pharmaceutical products and medical supplies to military and federal healthcare systems globally. AmerisourceBergen Drug Corp, a major pharmaceutical distributor headquartered in Pennsylvania, is a critical vendor in the federal medical supply chain serving the Defense Health Agency, U.S. Coast Guard, and other government healthcare systems. The company's federal contract portfolio demonstrates extensive experience delivering a broad range of pharmaceutical products including medications, vaccines, medical devices, and specialized healthcare commodities across multiple therapeutic domains. All of the company's reviewed contract awards have been competitively awarded without set-aside designations, reflecting its capability to meet federal procurement requirements through open competition.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $1.4k | 5/27/25 |